You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

JNJ-54179060

Showing 1 - 25 of 437
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma Trial (Ibrutinib, Venetoclax)

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Small Lymphocytic Lymphoma
  • (no location specified)
Jul 19, 2023

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin Trial in Worldwide (JNJ-67856633, Ibrutinib)

Active, not recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Lymphoma, Non-Hodgkin
  • Copenhagen, Denmark
  • +9 more
Jan 27, 2023

CNS Lymphoma Trial in Petah Tikva (Imbruvica)

Recruiting
  • Central Nervous System Lymphoma
  • Petah Tikva, Israel
    Hematology Institute
May 9, 2022

Waldenstrom Macroglobulinemia Trial in China (Ibrutinib)

Active, not recruiting
  • Waldenstrom Macroglobulinemia
  • Changchun, China
  • +5 more
Jan 27, 2023

GVHD Trial in Japan (Ibrutinib)

Completed
  • Graft vs Host Disease
  • Anjo-shi, Japan
  • +14 more
Dec 30, 2021

Gastrooesophageal Cancer Trial in Sutton (ibrutinib)

Unknown status
  • Gastrooesophageal Cancer
  • Sutton, Surrey, United Kingdom
    The Royal Marsden NHS Trust
Sep 17, 2019

Lymphocytic Leukemia Trial in Japan (Ibrutinib)

Completed
  • Lymphocytic Leukemia
  • Fukuoka-city, Japan
  • +7 more
Aug 12, 2019

Lymphoma, Mantle-Cell Trial in Worldwide (Ibrutinib, Lenalidomide, Rituximab)

Recruiting
  • Lymphoma, Mantle-Cell
  • Barretos, Brazil
  • +150 more
Jan 27, 2023

Ibrutinib in Steroid Dependent/Refractory cGVHD Participants

Recruiting
  • Chronic Graft vs Host Disease
    • Bucheon-Si, Korea, Republic of
    • +9 more
    Jan 27, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)

    Enrolling by invitation
    • Chronic Lymphocytic Leukemia
    • +6 more
    • Duarte, California
    • +165 more
    Mar 24, 2022

    Indolent Non-Hodgkin Lymphoma Trial in München (Ibrutinib, GA 101)

    Active, not recruiting
    • Indolent Non-Hodgkin Lymphoma
    • München, Bavaria, Germany
      Klinikum der Universität München
    May 6, 2021

    Advanced Prostate Cancer Trial in Lyon, Villejuif, Rotterdam (JNJ-78278343, JNJ-87189401)

    Not yet recruiting
    • Advanced Prostate Cancer
    • Lyon, France
    • +2 more
    Oct 18, 2023

    Myeloproliferative Disorders, Essential Thrombocythemia, Tumors Trial (JNJ-88549968)

    Not yet recruiting
    • Myeloproliferative Disorders
    • +3 more
    • (no location specified)
    Nov 21, 2023

    Lymphoma, Non-Hodgkin Trial (JNJ-87801493, JNJ-80948543, JNJ-75348780)

    Not yet recruiting
    • Lymphoma, Non-Hodgkin
    • (no location specified)
    Nov 15, 2023

    Healthy Trial in Lincoln (JNJ-68179280, Placebo)

    Recruiting
    • Healthy
    • Lincoln, Nebraska
      Celerion
    Jan 17, 2023

    Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide (Abiraterone Acetate, Prednisone,

    Active, not recruiting
    • Prostatic Neoplasms
    • Metastatic Castration-Resistant Prostate Cancer
    • Abiraterone Acetate
    • +2 more
    • Los Angeles, California
    • +6 more
    Jan 18, 2023

    Metastatic Castration-resistant Prostate Tumors Trial in Australia, Korea, Republic of, United States (JNJ-78278343, Cetrelimab)

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Neoplasms
    • Sarasota, Florida
    • +7 more
    Apr 6, 2023

    Tumors, Solid Tumor, Adult, Non-Hodgkin Lymphoma Trial in Worldwide (JNJ-64619178)

    Active, not recruiting
    • Neoplasms
    • +3 more
    • Sarasota, Florida
    • +17 more
    Jan 27, 2023

    Waldenstrom Macroglobulinemia Trial in Japan (Ibrutinib, Rituximab)

    Active, not recruiting
    Has Results
    • Waldenstrom Macroglobulinemia
    • Chiba, Japan
    • +8 more
    Jan 27, 2023

    Multiple Myeloma Trial in Belgium, Israel, Spain (Daratumumab, JNJ-63723283)

    Completed
    Has Results
    • Multiple Myeloma
    • Antwerpen, Belgium
    • +12 more
    Dec 1, 2022

    Healthy Trial in Leiden (JNJ-69095897, Placebo)

    Recruiting
    • Healthy
    • Leiden, Netherlands
      Centre for Human Drug Research
    Jan 31, 2023

    Plaque Psoriasis Trial in United States (JNJ-77242113, Placebo)

    Recruiting
    • Plaque Psoriasis
    • Rolling Meadows, Illinois
    • +8 more
    Oct 18, 2023

    Relapsed or Refractory Multiple Myeloma Trial in Worldwide (JNJ-79635322)

    Recruiting
    • Relapsed or Refractory Multiple Myeloma
    • Edegem, Belgium
    • +16 more
    Jan 27, 2023

    Multiple Myeloma Trial in Japan, United States (JNJ-68284528)

    Completed
    • Multiple Myeloma
    • JNJ-68284528
    • Phoenix, Arizona
    • +20 more
    Oct 5, 2022

    Healthy Trial in Merksem (JNJ-67835989, Placebo)

    Completed
    • Healthy
    • Merksem, Belgium
      Clinical Pharmacology Unit
    Jul 20, 2022